AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy
AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...
Investing.com India7h
5 big analyst AI moves: Chip stocks at risk due to tariffs; ASML downgraded
In a recent customer survey, Mizuho found that “sales cycles slowed modestly,” especially in financial services, though the ...